Zhejiang Dayang Biology Technology Co.,Ltd.
003017.SZ · SHZ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | CN¥1,517,459 | CN¥1,963,453 | CN¥1,612,328 | CN¥1,795,373 |
| - Cash | CN¥353,991 | CN¥382,366 | CN¥131,111 | CN¥131,883 |
| + Debt | CN¥358,057 | CN¥249,496 | CN¥282,143 | CN¥179,739 |
| Enterprise Value | CN¥1,521,525 | CN¥1,830,583 | CN¥1,763,359 | CN¥1,843,229 |
| Revenue | CN¥909,956 | CN¥919,451 | CN¥1,058,105 | CN¥783,209 |
| % Growth | -1% | -13.1% | 35.1% | – |
| Gross Profit | CN¥177,898 | CN¥166,276 | CN¥146,255 | CN¥152,163 |
| % Margin | 19.6% | 18.1% | 13.8% | 19.4% |
| EBITDA | CN¥147,093 | CN¥122,803 | CN¥123,183 | CN¥125,393 |
| % Margin | 16.2% | 13.4% | 11.6% | 16% |
| Net Income | CN¥63,746 | CN¥50,007 | CN¥80,727 | CN¥70,009 |
| % Margin | 7% | 5.4% | 7.6% | 8.9% |
| EPS Diluted | 0.78 | 0.62 | 0.99 | 1.16 |
| % Growth | 25.8% | -37.4% | -14.7% | – |
| Operating Cash Flow | CN¥66,194 | CN¥182,423 | CN¥91,887 | -CN¥35,156 |
| Capital Expenditures | -CN¥63,450 | -CN¥103,627 | -CN¥104,651 | -CN¥93,433 |
| Free Cash Flow | CN¥2,744 | CN¥78,796 | -CN¥12,764 | -CN¥128,589 |